WuXi XDC is a leading CRDMO focused on the global ADC and broader bioconjugate market and is dedicated to providing integrated services from concept development to commercialization. All services are provided from proximately located, state-of-the-art laboratories and manufacturing facilities, providing high efficiency and significant reduction of development timeline and costs. Our community of over 1000 skilled employees work across a global network to provide an open-access platform with the most comprehensive capabilities and technologies. WuXi XDC enables its biopharmaceutical partners to innovate, accelerate, and transform the development of the bioconjugate industry, to the benefit of patients worldwide.
Company Details
- Employees
- 161
- Founded
- -
- Address
- Key Challenges In Bioconjugate Development
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.wuxixdc.com
Wuxi Xdc Questions
Wuxi Xdc's website is https://www.wuxixdc.com
Wuxi Xdc's LinkedIn profile is https://www.linkedin.com/company/wuxi-xdc
Wuxi Xdc has
161 employees.
View email and phone details for 161
employees at Wuxi Xdc.
Wuxi Xdc's industry is
Pharmaceutical Manufacturing
Wuxi Xdc's top competitors are
Amgen,
Novartis Singapore,
Wuxi Biologics,
Thermo Fisher Scientific,
Abbvie,
Sanofi,
Wuxi Apptec,
Roche,
Biontech Se,
Lonza.
Wuxi Xdc's categories are Pharmaceutical Manufacturing
Wuxi Xdc's founding year is 2021
